ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

More than 100,000 dementia patients are given anti-psychotic drugs that 'may kill'

Updated on April 28, 2008
 

Thousands of dementia patients are being given dangerous anti-psychotic drugs just to keep them quiet, an official report has found.

The medication, which could increase the risk of premature death, is prescribed to control agitation, delusions, sleep disturbance and aggression. It is not licensed to treat Alzheimer's.

But an official investigation has found that care-home staff are using the drugs as a first resort to control the behaviour of difficult patients with dementia.

A report from the all-party parliamentary group on dementia warns that almost three-quarters of those taking the drugs, up to 105,000, are given them inappropriately - at a cost of more than £60million a year.

There is also evidence that side effects can double the risk of users dying prematurely.

Like a zombie: Lily Frost

The report, called A Last Resort, says there is no regulation of their use and urges the Government to stop their over-prescription.

MPs are calling for three-monthly checks on Alzheimer's patients taking "dangerous" anti-psychotic drugs, to review their condition.

They believe families should to be involved when the drugs are prescribed.

The report also calls for specialist dementia training for all care staff, more pro-active support for staff from GPs, community psychiatric nurses and psychiatrists, and a cost-effectiveness review and national audit.

Jeremy Wright, chairman of the all-party group, said: "A Last Resort shines a light on one of the darkest areas of dementia care.

"Anti-psychotics can double risk of death and triple risk of stroke in people with dementia, heavily sedate them and accelerate cognitive decline. The Government must end this needless abuse.

"Best practice guidelines are not enough - safeguards must be put in place to ensure anti-psychotics are always a last resort."

Typical drugs used for dementia symptoms are Largactil, Serenace, Stelazine and Risperdal, which were originally designed to treat schizophrenia patients.

Neil Hunt, of the Alzheimer's Society, said: "It is absolutely disgraceful that the widespread abuse of people with dementia has been allowed to continue despite safety warnings on anti-psychotics."

Safe alternatives to anti-psychotics are available, Mr Hunt said.

Coupled with staff training, these could improve patients' treatment, he believes.

"Over 70 per cent of people with dementia experience challenging behaviour at some point during illness.

"More often than not this is an expression of unmet need, not a symptom of dementia. And there is no excuse for reaching for the medicine cabinet."

Lily Frost, 86, was prescribed anti-psychotic drugs in August. She died in October.

The former dinner lady was given powerful tranquillisers to calm her agitation at night.

But soon she was sleeping all day and could not hold a pen unaided.

Before dying, the widow had a stroke, pneumonia and a burst ulcer.

Her daughter Brenda Vickers, 56, of Chester, said: "The change was rapid. She was laughing and happy before she went to hospital and came out like a zombie. I was told she was given the drug for her safety. I think it was to keep her quiet during the day."

Care Services Minister Ivan Lewis said the report "raises issues of serious concern".

"Inappropriate administration of medication is entirely unacceptable. Guidance to health professionals and care staff is very clear, anti-psychotic drugs should only be used when they are appropriate as part of best clinical care practice."

The National Dementia Strategy due to be published this year, will address medication, he said.

Source

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)